PMID- 20347132 OWN - NLM STAT- MEDLINE DCOM- 20100727 LR - 20181201 IS - 1878-5905 (Electronic) IS - 0142-9612 (Linking) VI - 31 IP - 19 DP - 2010 Jul TI - Incorporation of tripolyphosphate nanoparticles into fibrous poly(lactide-co-glycolide) scaffolds for tissue engineering. PG - 5100-9 LID - 10.1016/j.biomaterials.2010.03.004 [doi] AB - Poly(lactide-co-glycolide) (PLGA) has been widely used for scaffolding materials in tissue engineering. It degrades mainly via hydrolysis of the ester bonds into lactic acid and glycolic acid leading to the decrease in pH of the surrounding microenvironment. The current study was designed to quickly neutralize the acidic degradation products of PLGA fibrous scaffolds by incorporating tripolyphosphate (TPP) nanoparticles into PLGA fibers. A homogeneous mixture of PLGA and TPP was first obtained by water-in-oil emulsion-dispersion followed by freeze-drying. The dried blend was melt-spun to yield fibers which were processed into scaffolds and subsequently immersed into phosphate-buffered saline (PBS) to verify the degradation properties. The pH of the saline was monitored for a duration of 80 days. The amount of TPP was optimized to obtain a PLGA based scaffolds without acidic degradation problems. Cellular compatibility of the modified and pristine scaffolds was evaluated using rabbit adipose-derived stem cells (rASCs). It was shown that TPP particles within the fibers were roughly 100nm in diameter and mainly located inside fibers instead of on the superficial layer. The acidic degradation of PT-16 and PT-64 (PT-X is termed when the monomer molar ratio of TPP to PLGA was 1:X) was significantly improved as the pH values of their respective solutions were maintained in a well neutralized state during the degradation. PT-64 and PT-16 scaffolds could well support the attachment and proliferation of rASCs. Hence, the incorporation of TPP nanoparticles via an emulsion-dispersion method could be an effective strategy to improve/adjust the acidic degradation of PLGA and further pave the way for clinical applications of such polyesters. CI - Copyright 2010 Elsevier Ltd. All rights reserved. FAU - Xie, Shujun AU - Xie S AD - National Tissue Engineering Center of China, No.100, Qin Zhou Road, Shanghai 200235, China. FAU - Zhu, Qin AU - Zhu Q FAU - Wang, Bin AU - Wang B FAU - Gu, Huijie AU - Gu H FAU - Liu, Wei AU - Liu W FAU - Cui, Lei AU - Cui L FAU - Cen, Lian AU - Cen L FAU - Cao, Yilin AU - Cao Y LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20100327 PL - Netherlands TA - Biomaterials JT - Biomaterials JID - 8100316 RN - 0 (Biocompatible Materials) RN - 0 (Polyphosphates) RN - 1SIA8062RS (Polylactic Acid-Polyglycolic Acid Copolymer) RN - 26009-03-0 (Polyglycolic Acid) RN - 33X04XA5AT (Lactic Acid) RN - NU43IAG5BC (triphosphoric acid) SB - IM MH - Adipocytes/*cytology/*physiology MH - Animals MH - Biocompatible Materials/chemistry MH - Cell Proliferation MH - Cells, Cultured MH - Equipment Design MH - Equipment Failure Analysis MH - Lactic Acid/*chemistry MH - Materials Testing MH - Nanoparticles/*chemistry/ultrastructure MH - Particle Size MH - Polyglycolic Acid/*chemistry MH - Polylactic Acid-Polyglycolic Acid Copolymer MH - Polyphosphates/*chemistry MH - Rabbits MH - Tissue Engineering/*instrumentation/methods MH - *Tissue Scaffolds EDAT- 2010/03/30 06:00 MHDA- 2010/07/28 06:00 CRDT- 2010/03/30 06:00 PHST- 2010/01/04 00:00 [received] PHST- 2010/03/02 00:00 [accepted] PHST- 2010/03/30 06:00 [entrez] PHST- 2010/03/30 06:00 [pubmed] PHST- 2010/07/28 06:00 [medline] AID - S0142-9612(10)00344-3 [pii] AID - 10.1016/j.biomaterials.2010.03.004 [doi] PST - ppublish SO - Biomaterials. 2010 Jul;31(19):5100-9. doi: 10.1016/j.biomaterials.2010.03.004. Epub 2010 Mar 27.